Hevia Ojanguren C - Search Results

Year	Number of Results
1994	1
2014	2
2015	1
2016	1
2019	1
2021	1
2023	2
2024	2

1

Effectiveness and safety of ferric carboxymaltose therapy in peritoneal dialysis patients: an observational study.

Portolés-Pérez J, Durá-Gúrpide B, Merino-Rivas JL, Martín-Rodriguez L, Hevia-Ojanguren C, Burguera-Vion V, Yuste-Lozano C, Sánchez-García L, Rodriguez-Palomares JR, Paraiso V; GCDP Study Group. Portolés-Pérez J, et al. Among authors: hevia ojanguren c. Clin Kidney J. 2019 Nov 22;14(1):174-180. doi: 10.1093/ckj/sfz153. eCollection 2021 Jan. Clin Kidney J. 2019. PMID: 33564416 Free PMC article.

2

Predictors of Subclinical Atheromatosis Progression over 2 Years in Patients with Different Stages of CKD.

Gracia M, Betriu À, Martínez-Alonso M, Arroyo D, Abajo M, Fernández E, Valdivielso JM; NEFRONA Investigators. Gracia M, et al. Clin J Am Soc Nephrol. 2016 Feb 5;11(2):287-96. doi: 10.2215/CJN.01240215. Epub 2015 Dec 14. Clin J Am Soc Nephrol. 2016. PMID: 26668022 Free PMC article.

3

Gender-specific risk factors and outcomes of hyperkalemia in CKD patients: smoking as a driver of hyperkalemia in men.

Valdivielso JM, Carriazo S, Martin M, Fernandez-Fernandez B, Bermudez-López M, Ortiz A; NEFRONA investigators. Valdivielso JM, et al. Clin Kidney J. 2023 Oct 9;17(1):sfad212. doi: 10.1093/ckj/sfad212. eCollection 2024 Jan. Clin Kidney J. 2023. PMID: 38186899 Free PMC article.

4

Prevalence of subclinical atheromatosis and associated risk factors in chronic kidney disease: the NEFRONA study.

Betriu A, Martinez-Alonso M, Arcidiacono MV, Cannata-Andia J, Pascual J, Valdivielso JM, Fernández E; Investigators from the NEFRONA Study. Betriu A, et al. Nephrol Dial Transplant. 2014 Jul;29(7):1415-22. doi: 10.1093/ndt/gfu038. Epub 2014 Feb 28. Nephrol Dial Transplant. 2014. PMID: 24586070

5

Observational multicenter study to evaluate the prevalence and prognosis of subclinical atheromatosis in a Spanish chronic kidney disease cohort: baseline data from the NEFRONA study.

Arroyo D, Betriu A, Martinez-Alonso M, Vidal T, Valdivielso JM, Fernández E; investigators from the NEFRONA study. Arroyo D, et al. BMC Nephrol. 2014 Oct 18;15:168. doi: 10.1186/1471-2369-15-168. BMC Nephrol. 2014. PMID: 25326683 Free PMC article.

6

Matrix Gla protein polymorphism rs1800802 is associated with atheroma plaque progression and with cardiovascular events in a chronic kidney disease cohort.

Cambray S, Bermúdez-López M, Garcia-Carrasco A, Valdivielso JM; NEFRONA investigators. Cambray S, et al. Clin Kidney J. 2023 Oct 10;17(1):sfad257. doi: 10.1093/ckj/sfad257. eCollection 2024 Jan. Clin Kidney J. 2023. PMID: 38186884 Free PMC article.

7

[Immunity and malnutrition in alcoholic liver diseases].

Hevia Ojanguren C, Fanjul Cabeza B, González Vázquez MI, Linares Rodríguez A, Rodrigo Sáez L. Hevia Ojanguren C, et al. An Med Interna. 1994 Oct;11(10):479-82. An Med Interna. 1994. PMID: 7865653 Spanish.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

7 results

Results by year

Search Page

Filters

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

Search Results

7 results

Results by year